Showing results (881-890 of 1,202) with videos related to
Sort By:
Pageof 121
BMJ Open|June 10, 2024
ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care (EMBRACE) randomised controlled trial protocolMichael E Rezaee, Katherine M Mahon, Bruce J Trock, et al.European Journal of Radiology|July 18, 2017
Preoperative breast MR Imaging in patients with primary breast cancer has the potential to decrease the rate of repeated surgeriesH Preibsch, G Blumenstock, E Oberlechner, et al.Archives of Gynecology and Obstetrics|March 5, 2023
Back to the future: breast surgery with tumescent local anesthesia (TLA)?B Boeer, G Helms, J Pasternak, et al.Cancer|November 27, 2014
A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancerPenny Fang, Rosemarie Mick, Curtiland Deville, et al.Cancer Journal (Sudbury, Mass.)|April 26, 2016
Preclinical Rationale and Clinical Considerations for Radiotherapy Plus Immunotherapy: Going Beyond Local ControlJonathan E Schoenhals, Steven N Seyedin, Chad Tang, et al.International Journal of Radiation Oncology, Biology, Physics|November 6, 2013
Burnout in United States academic chairs of radiation oncology programsAaron S Kusano, Charles R Thomas, James A Bonner, et al.Cancer Research|September 20, 2006
Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapyNabendu Pore, Anjali K Gupta, George J Cerniglia, et al.Virology|June 20, 1995
CTL escape viral variants. I. Generation and molecular characterizationH Lewicki, A Tishon, P Borrow, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 22, 2017
Patterns and correlates of treatment failure in relation to isodose distribution in non-small cell lung cancer: An analysis of 1522 patients in the modern eraTodd A Pezzi, Chad Tang, Cameron W Swanick, et al.European Radiology|September 19, 2015
Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: correlation with tumour responseH Preibsch, L Wanner, S D Bahrs, et al.Pageof 121